XR Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,300
Closed -$211K 85
2024
Q3
$211K Sell
1,300
-500
-28% -$79.7K 0.06% 165
2024
Q2
$263K Sell
1,800
-600
-25% -$89.2K 0.05% 202
2024
Q1
$380K Sell
2,400
-5,000
-68% -$796K 0.01% 235
2023
Q4
$1.16M Sell
7,400
-300
-4% -$46K 0.04% 176
2023
Q3
$1.2M Sell
7,700
-14,600
-65% -$2.41M 0.09% 150
2023
Q2
$3.69M Buy
22,300
+7,700
+53% +$1.24M 0.18% 47
2023
Q1
$2.26M Buy
14,600
+10,200
+232% +$1.65M 0.06% 101
2022
Q4
$777K Buy
+4,400
New +$760K 0.08% 199
2022
Q3
Sell
-10,100
Closed -$20K 415
2022
Q2
$20K Buy
+10,100
New +$1.8M 0.01% 303
2021
Q2
Sell
-11,400
Closed -$34K 478
2021
Q1
$34K Buy
+11,400
New +$1.84M ﹤0.01% 372
2019
Q3
Sell
-20,500
Closed -$55K 275
2019
Q2
$55K Buy
+20,500
New +$2.84M 0.01% 176

Other funds holding JNJ

XR Securities's JNJ Position: Q2 2023 in Review

XR Securities sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 3,991 shares — an estimated $644K sold.

XR Securities first reported a position in JNJ in Q2 2018 and held it in 12 quarters. The position peaked at $6.89M in Q4 2018. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • XR Securities reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • XR Securities sold 3,991 Johnson & Johnson shares in Q2 2023, an estimated $644K.
  • XR Securities first reported a position in Johnson & Johnson in Q2 2018 and held it in 12 quarters.
  • XR Securities's Johnson & Johnson position peaked at $6.89M in Q4 2018.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.